Novacyt SA NYZ

Morningstar Rating
€0.40 −0.04 (9.34%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

NYZ is trading at a LOCK|?#FVY premium.
Price
€0.40
Fair Value
LOCK|&#cgjd
Uncertainty
LOCK|j! sFLW&
1-Star Price
LOCK|l@$Kfjc
5-Star Price
LOCK|QZZ%&g%
Economic Moat
LOCK|s>m
Capital Allocation
—

Trading Information

Previous Close Price
€0.44
Day Range
€0.40–0.43
52-Week Range
€0.36–0.72
Bid/Ask
€0.00 / €0.00
Shares Outstanding
72.47M
Market Cap
€28.84M
Volume/Avg
— / —

Key Statistics

Price/Earnings (Normalized)
—
Price/Sales
1.13
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Dividend Payment Schedule
—
Total Yield
—

Company Profile

Novacyt SA is engaged in developing and selling diagnostic products for cancer and infectious diseases. The company operates its business through the following business segments: Primer Design, Yourgene Health and Corporate. Majority of the revenue is generated from Yourgene Health segment. Geographically, the company operates in United Kingdom, France, Europe, America, Asia-Pacific, Middle East and Africa generating majority from Asia- pacific region.
Sector
Healthcare
Industry
Diagnostics & Research
Stock Style Box
Small Value
Total Number of Employees
216

Valuation

Metric
NYZ
Price/Earnings (Normalized)
—
Price/Book Value
1.33
Price/Sales
1.13
Price/Cash Flow
—
Price/Earnings
NYZ

Financial Strength

Metric
NYZ
Quick Ratio
2.19
Current Ratio
3.14
Interest Coverage
−44.85
Quick Ratio
NYZ

Profitability

Metric
NYZ
Return on Assets (Normalized)
−15.00%
Return on Equity (Normalized)
−25.49%
Return on Invested Capital (Normalized)
−17.17%
Return on Assets
NYZ

Diagnostics & Research Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Thermo Fisher Scientific Inc
TMO
LOCK|sBp?N#JLOCK|?mR$248B
Danaher Corp
DHR
LOCK|yQZczZ^LOCK|!y$155B
IDEXX Laboratories Inc
IDXX
LOCK|%$w#T>snLOCK|Z<S$53B
Agilent Technologies Inc
A
LOCK|k#$D?X&LOCK|Fd%$48B
Waters Corp
WAT
LOCK|Vyy$Y^vLOCK|x<$$43B
IQVIA Holdings Inc
IQV
LOCK|@p$&QcLOCK|r!<Z$41B
Mettler-Toledo International Inc
MTD
LOCK|Lymz<VmLOCK|%zz?$33B
Labcorp Holdings Inc
LH
LOCK|xKkpccz^LOCK|?B<Pn$30B
Illumina Inc
ILMN
LOCK|BvM!!ZSLOCK|?b$h$29B
Quest Diagnostics Inc
DGX
LOCK|>>!JN#GLOCK|y$jy$28B

Sponsor Center